Dietary modifications can help prevent many cardiovascular disease (CVD) events.
Endothelial progenitor cells (EPCs) actively contribute to cardiovascular system …

Circulating endothelial progenitor cells (EPCs) derived from bone marrow were isolated for
the first time in 1997 and characterized. Recent evidence has indicated that EPCs contribute …

For more than a decade, endothelial progenitor cells (EPCs) have been implicated in
cardiovascular homeostasis. EPCs are believed to reside within the bone marrow in close …

Stimulated by the leading mortalities of cardiovascular diseases (CVDs), various types of
cardiovascular biomaterials have been widely investigated in the past few decades …

Circulating endothelial progenitor cells (EPCs) have been demonstrated to correlate
negatively with vascular endothelial dysfunction and cardiovascular risk factors. However …

ABSTRACT Background Endothelial progenitor cells (EPCs) and microparticles are
emerging as novel markers of cardiovascular disease (CVD) risk, which could potentially be …

Endothelial dysfunction, which is considered the functional equivalent of a disrupted
balance between endothelial injury and repair, precedes overt atherosclerosis by many …

The disease burden of diabetes mellitus (DM) and its associated cardiovascular
complications represent a growing and major global health problem. Recent studies suggest …

Emerging evidences indicate that endothelial progenitor cells (EPCs) actively contribute in
regulating cardiovascular homeostasis, and interest is growing for possible future diagnostic …

Advanced knowledge in the field of stem cell biology and their ability to provide a cue for
counteracting several diseases are leading numerous researchers to focus their attention on …